Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coli

PLoS One. 2018 Sep 24;13(9):e0204457. doi: 10.1371/journal.pone.0204457. eCollection 2018.

Abstract

Background: Fatty acid synthase 1 (FAS I) from Mycobacterium tuberculosis (Mtb) is an essential protein and a promising drug target. FAS I is a multi-functional, multi-domain protein that is organized as a large (1.9 MDa) homohexameric complex. Acyl intermediates produced during fatty acid elongation are attached covalently to an acyl carrier protein (ACP) domain. This domain is activated by the transfer of a 4'-Phosphopantetheine (4'-PP, also termed P-pant) group from CoA to ACP catalyzed by a 4'-PP transferase, termed acyl carrier protein synthase (AcpS).

Methods: In order to obtain an activated FAS I in E. coli, we transformed E. coli with tagged Mtb fas1 and acpS genes encoded by a separate plasmid. We induced the expression of Mtb FAS I following induction of AcpS expression. FAS I was purified by Strep-Tactin affinity chromatography.

Results: Activation of Mtb FAS I was confirmed by the identification of a bound P-pant group on serine at position 1808 by mass spectrometry. The purified FAS I displayed biochemical activity shown by spectrophotometric analysis of NADPH oxidation and by CoA production, using the Ellman reaction. The purified Mtb FAS I forms a hexameric complex shown by negative staining and cryo-EM.

Conclusion: Purified hexameric and active Mtb FAS I is required for binding and drug inhibition studies and for structure-function analysis of this enzyme. This relatively simple and short procedure for Mtb FAS I production should facilitate studies of this enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents
  • Bacterial Proteins / genetics
  • Bacterial Proteins / isolation & purification
  • Bacterial Proteins / metabolism*
  • Bacterial Proteins / ultrastructure
  • Drug Discovery
  • Escherichia coli / enzymology*
  • Escherichia coli / genetics
  • Fatty Acid Synthases / genetics
  • Fatty Acid Synthases / isolation & purification
  • Fatty Acid Synthases / metabolism*
  • Fatty Acid Synthases / ultrastructure
  • Genetic Vectors
  • Mycobacterium tuberculosis / enzymology*
  • Mycobacterium tuberculosis / genetics
  • Protein Binding
  • Recombinant Proteins / genetics
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism*
  • Recombinant Proteins / ultrastructure
  • Transformation, Bacterial

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • Recombinant Proteins
  • Fatty Acid Synthases

Grants and funding

The work was supported by the following: Legacy Heritage Clinical Research Initiative of the Israel Science Foundation, Grant No. 1629/10, and the Israeli Ministry of Health Chief Scientist award No. 6223 to OZ; and The Ministry of Aliyah and Immigrant Absorption grant no. 17733 to Dr Szilvia Baron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.